Nerve Growth Factor as a Signaling Molecule for Nerve Cells and also for the Neuroendocrine-Immune Systems

被引:28
作者
Fiore, Marco
Chaldakov, George N. [2 ]
Aloe, Luigi [1 ]
机构
[1] CNR, NGF Sect, Inst Neurobiol & Mol Med, Natl Res Council,EBRI, I-00143 Rome, Italy
[2] Med Univ, Div Cell Biol, Varna, Bulgaria
关键词
inflammation; mast cells; NGF; neurotrophins; NEUROTROPHIN RECEPTOR EXPRESSION; HUMAN CORONARY ATHEROSCLEROSIS; FETAL ALCOHOL SYNDROME; MAST-CELLS; MESSENGER-RNA; SENSORY NEURONS; BRAIN NGF; NEUROLOGICAL DISORDERS; AGGRESSIVE-BEHAVIOR; TOPICAL APPLICATION;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Nerve growth factor (NGF) is a signaling molecule, originally discovered for its role on differentiation and survival of peripheral sensory and sympathetic neurons. It has also been associated with functional activities of cells of the immune and endocrine systems. NGF biological activity is mediated by two classes of receptors: (i) p75 neurotrophin receptor (p75(NTR)), a 75 kDa glycoprotein, belonging to a superfamily of cytokine receptors including TNF receptors, and (ii) TrkA, a transmembrane tyrosine kinase of 140 kDa. Both TrkA and p75(NTR) are known to play a marked action in neurodegenerative disorders, immune-related deficits, and neuroendocrine (including adipoendocrine) mechanisms. This review focuses on these cellular events and presents a working model which attempts to explain the close interrelationships of the neuro-endocrine-immune triad via a modulatory action of NGF.
引用
收藏
页码:133 / 145
页数:13
相关论文
共 130 条
[1]
Fetal alcohol syndrome: A cautionary note [J].
Abel, Emest L. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (12) :1521-1529
[2]
Nerve growth factor is a potential therapeutic target in breast cancer [J].
Adriaenssens, Eric ;
Vanhecke, Elsa ;
Saule, Pasquine ;
Mougel, Alexandra ;
Page, Adeline ;
Romon, Rodrigue ;
Nurcombe, Victor ;
Le Bourhis, Xuefen ;
Hondermarck, Hubert .
CANCER RESEARCH, 2008, 68 (02) :346-351
[3]
Keloid and hypertrophic medical hypotheses scar: Neurogenic inflammation hypotheses [J].
Akaishi, Satoshi ;
Ogawa, Rei ;
Hyakusoku, Hiko .
MEDICAL HYPOTHESES, 2008, 71 (01) :32-38
[4]
Alleva E, 1993, Rev Neurosci, V4, P41
[5]
Alleva E, 1999, Ann Ist Super Sanita, V35, P211
[6]
CHANGES OF NGF LEVEL IN MOUSE HYPOTHALAMUS FOLLOWING INTERMALE AGGRESSIVE-BEHAVIOR - BIOLOGICAL AND IMMUNOHISTOCHEMICAL EVIDENCE [J].
ALOE, L ;
ALLEVA, E ;
DESIMONE, R .
BEHAVIOURAL BRAIN RESEARCH, 1990, 39 (01) :53-61
[7]
Overexpression of tumour necrosis factor α in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyltransferase activity [J].
Aloe, L ;
Fiore, M ;
Probert, L ;
Turrini, P ;
Tirassa, P .
CYTOKINE, 1999, 11 (01) :45-54
[8]
NERVE GROWTH-FACTOR AND AUTOIMMUNE-DISEASES [J].
ALOE, L ;
SKAPER, SD ;
LEON, A ;
LEVIMONTALCINI, R .
AUTOIMMUNITY, 1994, 19 (02) :141-150
[9]
AGGRESSIVE-BEHAVIOR INDUCES RELEASE OF NERVE GROWTH-FACTOR FROM MOUSE SALIVARY-GLAND INTO THE BLOOD-STREAM [J].
ALOE, L ;
ALLEVA, E ;
BOHM, A ;
LEVIMONTALCINI, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) :6184-6187
[10]
Presence of nerve growth factor in the thymus of prenatal, postnatal and pregnant rats [J].
Aloe, L ;
Micera, A ;
Bracci-Laudiero, L ;
Vigneti, E ;
Turrini, P .
THYMUS, 1997, 24 (04) :221-231